Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial

Anna M Sawka, Sharon Straus, Gary Rodin, Lineke Heus, James D Brierley, Richard W Tsang, Lorne Rotstein, Shereen Ezzat, Phillip Segal, Amiram Gafni, Kevin E Thorpe, David P Goldstein, Anna M Sawka, Sharon Straus, Gary Rodin, Lineke Heus, James D Brierley, Richard W Tsang, Lorne Rotstein, Shereen Ezzat, Phillip Segal, Amiram Gafni, Kevin E Thorpe, David P Goldstein

Abstract

Background: Patient decision aids (P-DAs) inform medical decision making, but longer term effects are unknown. This article describes extended follow-up from a thyroid cancer treatment P-DA trial.

Methods: In this single-center, parallel-design randomized controlled trial conducted at a Canadian tertiary/quaternary care center, early-stage thyroid cancer patients from a P-DA trial were contacted 15 to 23 months after randomization/radioactive iodine (RAI) decision making to evaluate longer term outcomes. It was previously reported that the use of the computerized P-DA in thyroid cancer patients considering postsurgical RAI treatment significantly improved medical knowledge in comparison with usual care alone. The P-DA and control groups were compared for the following outcomes: feeling informed about the RAI treatment choice, decision satisfaction, decision regret, cancer-related worry, and physician trust. In a subgroup of 20 participants, in-depth interviews were conducted for a qualitative analysis.

Results: Ninety-five percent (70 of 74) of the original population enrolled in follow-up at a mean of 17.1 months after randomization. P-DA users perceived themselves to be significantly more 1) informed about the treatment choice (P = .008), 2) aware of options (P = .009), 3) knowledgeable about treatment benefits (P = .020), and 4) knowledgeable about treatment risks/side effects (P = .001) in comparison with controls. There were no significant group differences in decision satisfaction (P = .142), decision regret (P = .199), cancer-related worry (P = .645), mood (P = .211), or physician trust (P = .764). In the qualitative analysis, the P-DA was perceived to have increased patient knowledge and confidence in decision making.

Conclusions: The P-DA improved cancer survivors' actual and long-term perceived medical knowledge with no adverse effects. More research on the long-term outcomes of P-DA use is needed.

Keywords: decision aids; decision making; decision support techniques; iodine radioisotopes; patient satisfaction; qualitative research; thyroid cancer.

© 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

Figures

Figure 1
Figure 1
Participant flow in the study. RAI indicates radioactive iodine; RCT, randomized controlled study.

References

    1. Cancer Research UK. Thyroid cancer incidence statistics. . Accessed March 9, 2015.
    1. American Cancer Society . Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society; 2014.
    1. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, Canada: Canadian Cancer Society; 2014.
    1. EUCAN. Thyroid cancer. . Accessed March 9, 2015.
    1. Sawka AM, Straus S, Gafni A, et al. A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision‐making on adjuvant radioactive iodine treatment. Patient Educ Couns. 2011;84:e24‐e27.
    1. Sawka AM, Meiyappan S, David D, et al. A mixed methods evaluation of a computerized decision aid for patients considering radioactive iodine remnant ablation: developing person‐centered medicine for thyroid cancer. Int J Pers Cent Med. 2011;1:559‐563.
    1. Sawka AM, Straus S, Gafni A, et al. How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation? Clin Endocrinol (Oxf). 2011;74:419‐423.
    1. Sawka AM, Straus S, Brierley JD, et al. Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer—a randomized controlled trial. Trials. 2010;11:81.
    1. Sawka AM, Straus S, Rotstein L, et al. Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early‐stage papillary thyroid carcinoma. J Clin Oncol. 2012;10:2906‐2911.
    1. Sawka AM, Rilkoff H, Tsang RW, et al. The rationale of patients with early stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation. Thyroid. 2013;23:246‐247.
    1. Schulz KF, Altman DG, Moher D; CONSORT Group . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
    1. Edge SB, Byrd DR, Carducci MA, et al. AJCC Cancer Staging Manual. 7th ed New York, NY: Springer‐Verlag; 2009.
    1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer , Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167‐1214.
    1. Martinez LS, Schwartz JS, Freres D, et al. Patient‐clinician information engagement increases treatment decision satisfaction among cancer patients through feeling of being informed. Patient Educ Couns. 2009;77:384‐390.
    1. O'Connor AM. User Manual—Decision Regret Scale. . Updated 2003. Accessed January 12, 2015.
    1. Brehaut JC, O'Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making. 2003;23:281‐292.
    1. Gotay CC, Pagano IS. Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007;5:15.
    1. Bresner L, Banach R, Rodin G, et al. Cancer‐related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab. 2015;100:977‐985.
    1. Kroenke K, Spitzer RL, Williams JB, et al. An ultra‐brief screening scale for anxiety and depression: the PHQ‐4. Psychosomatics. 2009;50:613‐621.
    1. Lowe B, Wahl I, Rose M, et al. A 4‐item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire‐4 (PHQ‐4) in the general population. J Affect Disord. 2010;122:86‐95.
    1. Anderson LA, Dedrick RF. Development of the Trust in Physician Scale: a measure to assess interpersonal trust in patient‐physician relationships. Psychol Rep. 1990;67(pt 2):1091‐1100.
    1. Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed‐method studies. Res Nurs Health. 2000;23:246‐255.
    1. Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, IL: Aldine; 1967.
    1. Finlay L. “Outing” the researcher: the provenance, process, and practice of reflexivity. Qual Health Res. 2002;12:531‐545.
    1. Denzin LL, Lincoln YS. The Sage Handbook of Qualitative Research. 3rd ed Newbury Park, CA: Sage Publications; 2005:230.
    1. Kvale S. Interviews: An Introduction to Qualitative Research Interviewing. Thousand Oaks, CA: Sage Publications; 1996.
    1. Reissman CK. Narrative Analysis. Thousand Oaks, CA: Sage Publications; 1993.
    1. Czarniawska B. Narratives in Social Science Research. London, England: Sage Publications; 2004.
    1. Crouch M, McKenzie H. The logic of small samples in interview‐based qualitative research. Soc Sci Inf. 2006;45:83‐99.
    1. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions . Cochrane Database Syst Rev. 2014:CD001431.
    1. Trikalinos TA, Wieland LS, Adam GP, Zgodic A, Ntzani EE. Decision Aids for Cancer Screening and Treatment. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Comparative Effectiveness Reviews 145.
    1. Denig P, Schuling J, Haaijer‐Ruskamp F, Voorham J. Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ. 2014;349:g5651.
    1. Alden DL. Decision aid influences on factors associated with patient empowerment prior to cancer treatment decision making. Med Decis Making. 2014;34:884‐898.
    1. Joseph‐Williams N, Edwards A, Elwyn G. Power imbalance prevents shared decision making. BMJ. 2014;348:g3178.
    1. Sawka AM, Goldstein DP, Brierley JD, et al. The impact of thyroid cancer and post‐surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One. 2009;4:e4191.
    1. Roberts KJ, Lepore SJ, Urken ML. Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. J Cancer Educ. 2008;23:186‐191.
    1. Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8:394‐401.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться